{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:24:06Z","timestamp":1791267846772,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"1-4","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins & Other Lipid Mediators"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.prostaglandins.2011.09.001","type":"journal-article","created":{"date-parts":[[2011,9,17]],"date-time":"2011-09-17T05:35:33Z","timestamp":1316237733000},"page":"99-108","source":"Crossref","is-referenced-by-count":111,"title":["CYP-eicosanoids\u2014A new link between omega-3 fatty acids and cardiac disease?"],"prefix":"10.1016","volume":"96","author":[{"given":"Christina","family":"Westphal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Konkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf-Hagen","family":"Schunck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.prostaglandins.2011.09.001_bib0005","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","article-title":"Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease","volume":"106","author":"Kris-Etherton","year":"2002","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.prostaglandins.2011.09.001_bib0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jacc.2009.02.084","article-title":"Omega-3 polyunsaturated fatty acids and cardiovascular diseases","volume":"54","author":"Lavie","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.prostaglandins.2011.09.001_bib0015","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMra1008153","article-title":"n-3 fatty acids in cardiovascular disease","volume":"364","author":"De Caterina","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prostaglandins.2011.09.001_bib0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1196\/annals.1323.028","article-title":"Dietary fat and health: the evidence and the politics of prevention: careful use of dietary fats can improve life and prevent disease","volume":"1055","author":"Lands","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"21","key":"10.1016\/j.prostaglandins.2011.09.001_bib0025","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1161\/01.CIR.0000069566.78305.33","article-title":"Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils","volume":"107","author":"Leaf","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.prostaglandins.2011.09.001_bib0030","doi-asserted-by":"crossref","first-page":"1991S","DOI":"10.1093\/ajcn\/87.6.1991S","article-title":"Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death","volume":"87","author":"Mozaffarian","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1016\/j.prostaglandins.2011.09.001_bib0035","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.metabol.2005.05.026","article-title":"A systematic review and meta-analysis of the impact of omega-3 fatty acids on selected arrhythmia outcomes in animal models","volume":"54","author":"Matthan","year":"2005","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0040","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/HYPERTENSIONAHA.107.103143","article-title":"Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension","volume":"51","author":"Fischer","year":"2008","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.prostaglandins.2011.09.001_bib0045","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1253\/circj.CJ-11-0209","article-title":"Long-term treatment with eicosapentaenoic acid ameliorates myocardial ischemia\u2013reperfusion injury in pigs in vivo","volume":"75","author":"Gao","year":"2011","journal-title":"Circ J"},{"issue":"15","key":"10.1016\/j.prostaglandins.2011.09.001_bib0050","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2007.05.046","article-title":"Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs","volume":"50","author":"Sarrazin","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.prostaglandins.2011.09.001_bib0055","doi-asserted-by":"crossref","first-page":"H1814","DOI":"10.1152\/ajpheart.00771.2010","article-title":"Eicosapentaenoic acid prevents atrial fibrillation associated with heart failure in a rabbit model","volume":"300","author":"Kitamura","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"16","key":"10.1016\/j.prostaglandins.2011.09.001_bib0060","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","article-title":"Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico (GISSI)-Prevenzione","volume":"105","author":"Marchioli","year":"2002","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.prostaglandins.2011.09.001_bib0065","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.jacc.2005.02.079","article-title":"N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial","volume":"45","author":"Calo","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.prostaglandins.2011.09.001_bib0070","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1161\/CIRCULATIONAHA.109.852657","article-title":"Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men","volume":"120","author":"Virtanen","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2011.09.001_bib0075","doi-asserted-by":"crossref","DOI":"10.2459\/JCM.0b013e32834a13c1","article-title":"n-3 polyunsaturated fatty acids for the prevention of postoperative atrial fibrillation: a meta-analysis of randomized controlled trials","author":"Benedetto","year":"2011","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"8081","key":"10.1016\/j.prostaglandins.2011.09.001_bib0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(78)91505-2","article-title":"Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?","volume":"2","author":"Dyerberg","year":"1978","journal-title":"Lancet"},{"issue":"6 Suppl.","key":"10.1016\/j.prostaglandins.2011.09.001_bib0085","doi-asserted-by":"crossref","first-page":"1467S","DOI":"10.1093\/ajcn\/83.6.1467S","article-title":"Distribution, interconversion, and dose response of n-3 fatty acids in humans","volume":"83","author":"Arterburn","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.prostaglandins.2011.09.001_bib0090","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3181\/0711-MR-311","article-title":"The importance of the omega-6\/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases","volume":"233","author":"Simopoulos","year":"2008","journal-title":"Exp Biol Med (Maywood)"},{"issue":"15","key":"10.1016\/j.prostaglandins.2011.09.001_bib0095","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.296.15.1885","article-title":"Fish intake, contaminants, and human health: evaluating the risks and the benefits","volume":"296","author":"Mozaffarian","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardiores.2006.08.019","article-title":"Cardiovascular benefits of omega-3 fatty acids","volume":"73","author":"von Schacky","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.prostaglandins.2011.09.001_bib0105","doi-asserted-by":"crossref","first-page":"1997S","DOI":"10.1093\/ajcn\/87.6.1997S","article-title":"The omega-3 index as a risk factor for coronary heart disease","volume":"87","author":"Harris","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.prostaglandins.2011.09.001_bib0110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"issue":"31","key":"10.1016\/j.prostaglandins.2011.09.001_bib0115","doi-asserted-by":"crossref","first-page":"22254","DOI":"10.1074\/jbc.M703169200","article-title":"Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products","volume":"282","author":"Wada","year":"2007","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0005-2760(94)90255-0","article-title":"Complete discrimination of docosahexaenoate from arachidonate by 85kDa cytosolic phospholipase A2 during the hydrolysis of diacyl- and alkenylacylglycerophosphoethanolamine","volume":"1212","author":"Shikano","year":"1994","journal-title":"Biochim Biophys Acta"},{"issue":"3\u20135","key":"10.1016\/j.prostaglandins.2011.09.001_bib0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.plefa.2008.09.010","article-title":"Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease","volume":"79","author":"Rapoport","year":"2008","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"8","key":"10.1016\/j.prostaglandins.2011.09.001_bib0130","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbalip.2009.03.009","article-title":"Intracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids","volume":"1791","author":"Rosa","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0135","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cvr\/cvn346","article-title":"Eicosanoid signalling pathways in the heart","volume":"82","author":"Jenkins","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.prostaglandins.2011.09.001_bib0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11745-011-3554-0","article-title":"PGE2 release from tryptase-stimulated rabbit ventricular myocytes is mediated by calcium-independent phospholipase A2gamma","volume":"46","author":"Sharma","year":"2011","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0090-6980(84)90075-3","article-title":"Biosynthesis and biological activity of leukotriene B5","volume":"27","author":"Terano","year":"1984","journal-title":"Prostaglandins"},{"issue":"11","key":"10.1016\/j.prostaglandins.2011.09.001_bib0150","doi-asserted-by":"crossref","first-page":"8755","DOI":"10.1074\/jbc.R100062200","article-title":"The biochemistry of n-3 polyunsaturated fatty acids","volume":"277","author":"Jump","year":"2002","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.prostaglandins.2011.09.001_bib0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20081880","article-title":"Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions","volume":"206","author":"Serhan","year":"2009","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0165","doi-asserted-by":"crossref","first-page":"H153","DOI":"10.1152\/ajpheart.01057.2009","article-title":"Resolvin E1 protects the rat heart against reperfusion injury","volume":"299","author":"Keyes","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-2275(20)32049-6","article-title":"Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase","volume":"41","author":"Capdevila","year":"2000","journal-title":"J Lipid Res"},{"issue":"3 Pt 2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0175","first-page":"R607","article-title":"20-HETE and the kidney: resolution of old problems and new beginnings","volume":"277","author":"McGiff","year":"1999","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol Rev"},{"issue":"39","key":"10.1016\/j.prostaglandins.2011.09.001_bib0185","doi-asserted-by":"crossref","first-page":"36059","DOI":"10.1074\/jbc.R100030200","article-title":"Epoxygenase pathways of arachidonic acid metabolism","volume":"276","author":"Zeldin","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0190","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbapap.2010.09.009","article-title":"Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids","volume":"1814","author":"Konkel","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.prostaglandins.2011.09.001_bib0195","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.bbrc.2005.02.103","article-title":"Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily","volume":"329","author":"Barbosa-Sicard","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0200","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.abb.2008.01.002","article-title":"Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450","volume":"471","author":"Fer","year":"2008","journal-title":"Arch Biochem Biophys"},{"issue":"43","key":"10.1016\/j.prostaglandins.2011.09.001_bib0205","doi-asserted-by":"crossref","first-page":"32720","DOI":"10.1074\/jbc.M110.118406","article-title":"Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of omega-3 fatty acids","volume":"285","author":"Arnold","year":"2010","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.prostaglandins.2011.09.001_bib0210","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1194\/jlr.M003061","article-title":"Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450","volume":"51","author":"Lucas","year":"2010","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0090-6980(91)90093-U","article-title":"Urinary excretion of diols derived from eicosapentaenoic acid during n-3 fatty acid ingestion by man","volume":"42","author":"Knapp","year":"1991","journal-title":"Prostaglandins"},{"issue":"8","key":"10.1016\/j.prostaglandins.2011.09.001_bib0220","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1194\/M900193-JLR200","article-title":"Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters","volume":"51","author":"Shearer","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.prostaglandins.2011.09.001_bib0225","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-6980(02)00038-2","article-title":"Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases","volume":"68\u201369","author":"Capdevila","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"9","key":"10.1016\/j.prostaglandins.2011.09.001_bib0230","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1016\/S0021-9258(18)53266-X","article-title":"Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase","volume":"268","author":"Zeldin","year":"1993","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0235","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/abbi.1995.1059","article-title":"Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis","volume":"316","author":"Zeldin","year":"1995","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"10.1016\/j.prostaglandins.2011.09.001_bib0240","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1016\/S0021-9258(20)89484-8","article-title":"Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties","volume":"266","author":"Karara","year":"1991","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.prostaglandins.2011.09.001_bib0245","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.ki.5002394","article-title":"Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension","volume":"72","author":"Capdevila","year":"2007","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.prostaglandins.2011.09.001_bib0250","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/01.HYP.0000255173.50317.fc","article-title":"Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors","volume":"49","author":"Campbell","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0255","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tcm.2007.11.002","article-title":"Vascular cytochrome p450 enzymes: physiology and pathophysiology","volume":"18","author":"Fleming","year":"2008","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0260","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/1074248409358408","article-title":"Review article: epoxyeicosatrienoic acids: novel mediators of cardioprotection","volume":"15","author":"Nithipatikom","year":"2010","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.prostaglandins.2011.09.001_bib0265","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1161\/01.RES.0000146277.62128.6f","article-title":"Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway","volume":"95","author":"Nithipatikom","year":"2004","journal-title":"Circ Res"},{"issue":"1\u20134","key":"10.1016\/j.prostaglandins.2011.09.001_bib0270","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.prostaglandins.2006.05.017","article-title":"Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia\/reperfusion injury","volume":"82","author":"Seubert","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0275","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cardiores.2005.06.007","article-title":"Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia\/reperfusion injury revisited","volume":"68","author":"Gross","year":"2005","journal-title":"Cardiovasc Res"},{"issue":"19","key":"10.1016\/j.prostaglandins.2011.09.001_bib0280","doi-asserted-by":"crossref","first-page":"12551","DOI":"10.1074\/jbc.272.19.12551","article-title":"Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes","volume":"272","author":"Wu","year":"1997","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.prostaglandins.2011.09.001_bib0285","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.RES.0000139436.89654.c8","article-title":"Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42\/p44 MAPK pathway","volume":"95","author":"Seubert","year":"2004","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0290","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yjmcc.2008.09.711","article-title":"Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model","volume":"46","author":"Batchu","year":"2009","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.prostaglandins.2011.09.001_bib0295","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.yjmcc.2006.11.020","article-title":"Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts","volume":"42","author":"Gross","year":"2007","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"10.1016\/j.prostaglandins.2011.09.001_bib0300","doi-asserted-by":"crossref","first-page":"H2838","DOI":"10.1152\/ajpheart.00186.2008","article-title":"Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart","volume":"294","author":"Gross","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0305","doi-asserted-by":"crossref","first-page":"H47","DOI":"10.1152\/ajpheart.01084.2008","article-title":"Evidence for role of epoxyeicosatrienoic acids in mediating ischemic preconditioning and postconditioning in dog","volume":"297","author":"Gross","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0310","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1440-1681.2010.05464.x","article-title":"Cytochrome P450 2J3\/epoxyeicosatrienoic acids mediate the cardioprotection induced by ischaemic post-conditioning, but not preconditioning, in the rat","volume":"38","author":"Yu","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.prostaglandins.2011.09.001_bib0315","doi-asserted-by":"crossref","DOI":"10.1007\/s10557-011-6321-9","article-title":"Abdominal surgical incision induces remote preconditioning of trauma (RPCT) via activation of bradykinin receptors (BK2R) and the cytochrome P450 epoxygenase pathway in canine hearts","author":"Gross","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0320","doi-asserted-by":"crossref","first-page":"H37","DOI":"10.1152\/ajpheart.00983.2008","article-title":"Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity","volume":"297","author":"Zhang","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"49","key":"10.1016\/j.prostaglandins.2011.09.001_bib0325","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"Xu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0330","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.0811022106","article-title":"Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy","volume":"106","author":"Ai","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.prostaglandins.2011.09.001_bib0335","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ng.129","article-title":"Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease","volume":"40","author":"Monti","year":"2008","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0340","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/abio.2001.5044","article-title":"Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs","volume":"292","author":"Nithipatikom","year":"2001","journal-title":"Anal Biochem"},{"issue":"6","key":"10.1016\/j.prostaglandins.2011.09.001_bib0345","first-page":"1245","article-title":"Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel","volume":"37","author":"Gross","year":"2004","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0350","doi-asserted-by":"crossref","first-page":"H500","DOI":"10.1152\/ajpheart.00918.2005","article-title":"Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection","volume":"290","author":"Nithipatikom","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2011.09.001_bib0355","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1474-8673.2009.00429.x","article-title":"Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic\u2013reperfusion injury","volume":"29","author":"Yousif","year":"2009","journal-title":"Auton Autacoid Pharmacol"},{"issue":"5431","key":"10.1016\/j.prostaglandins.2011.09.001_bib0360","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.prostaglandins.2011.09.001_bib0365","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.109.147843","article-title":"Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB","volume":"55","author":"Rompe","year":"2010","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.prostaglandins.2011.09.001_bib0370","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.yjmcc.2009.01.009","article-title":"Protective actions of epoxyeicosatrienoic acid: dual targeting of cardiovascular PI3K and KATP channels","volume":"46","author":"Bodiga","year":"2009","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"10.1016\/j.prostaglandins.2011.09.001_bib0375","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.yjmcc.2009.02.028","article-title":"Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells","volume":"46","author":"Katragadda","year":"2009","journal-title":"J Mol Cell Cardiol"},{"issue":"Pt 3","key":"10.1016\/j.prostaglandins.2011.09.001_bib0380","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1469-7793.1998.777bp.x","article-title":"Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cells","volume":"508","author":"Xiao","year":"1998","journal-title":"J Physiol"},{"issue":"1\u20134","key":"10.1016\/j.prostaglandins.2011.09.001_bib0385","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.prostaglandins.2006.05.023","article-title":"Cyclic AMP-dependent modulation of cardiac L-type Ca2+ and transient outward K+ channel activities by epoxyeicosatrienoic acids","volume":"82","author":"Xiao","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"Pt 3","key":"10.1016\/j.prostaglandins.2011.09.001_bib0390","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1113\/jphysiol.2001.012896","article-title":"Activation of ATP-sensitive K(+) channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes","volume":"537","author":"Lu","year":"2001","journal-title":"J Physiol"},{"issue":"Pt 1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0395","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1469-7793.1999.0153o.x","article-title":"Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes","volume":"519","author":"Lee","year":"1999","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0400","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tcm.2005.03.001","article-title":"The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning","volume":"15","author":"Hausenloy","year":"2005","journal-title":"Trends Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.prostaglandins.2011.09.001_bib0405","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/01.RES.0000122392.33172.09","article-title":"Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts","volume":"94","author":"Gross","year":"2004","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.prostaglandins.2011.09.001_bib0410","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.yjmcc.2009.08.017","article-title":"Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: insight gained using metabolomic approaches","volume":"47","author":"Li","year":"2009","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0415","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/cvr\/cvq231","article-title":"Cardiac mitochondria and arrhythmias","volume":"88","author":"Brown","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.prostaglandins.2011.09.001_bib0420","doi-asserted-by":"crossref","first-page":"H1115","DOI":"10.1152\/ajpheart.00879.2009","article-title":"Role of the gap junction in ischemic preconditioning in the heart","volume":"298","author":"Miura","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0425","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.107.089599","article-title":"Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension","volume":"50","author":"Singh","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0430","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/jpet.107.130336","article-title":"20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells","volume":"324","author":"Ishizuka","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0435","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1124\/jpet.109.159863","article-title":"20-Hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling","volume":"332","author":"Cheng","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"21","key":"10.1016\/j.prostaglandins.2011.09.001_bib0440","doi-asserted-by":"crossref","first-page":"12701","DOI":"10.1073\/pnas.95.21.12701","article-title":"20-Hydroxyeicosatetraenoic acid mediates calcium\/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells","volume":"95","author":"Muthalif","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.prostaglandins.2011.09.001_bib0445","doi-asserted-by":"crossref","first-page":"L1061","DOI":"10.1152\/ajplung.00096.2005","article-title":"Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle","volume":"289","author":"Yaghi","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"10.1016\/j.prostaglandins.2011.09.001_bib0450","doi-asserted-by":"crossref","first-page":"H1109","DOI":"10.1152\/ajpheart.00067.2010","article-title":"20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca2+ channel via a PKC-dependent mechanism in cardiomyocytes","volume":"299","author":"Zeng","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.prostaglandins.2011.09.001_bib0455","first-page":"294","article-title":"20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways","volume":"57","author":"Bao","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"10.1016\/j.prostaglandins.2011.09.001_bib0460","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1124\/mol.62.5.1076","article-title":"Stereospecific activation of cardiac ATP-sensitive K(+) channels by epoxyeicosatrienoic acids: a structural determinant study","volume":"62","author":"Lu","year":"2002","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.prostaglandins.2011.09.001_bib0465","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1113\/expphysiol.2007.038166","article-title":"The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK alpha channel subunit in rodents","volume":"92","author":"Hercule","year":"2007","journal-title":"Exp Physiol"},{"issue":"2 Pt 2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0470","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/hy0202.103293","article-title":"Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators","volume":"39","author":"Lauterbach","year":"2002","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0475","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1124\/jpet.303.2.768","article-title":"Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels","volume":"303","author":"Ye","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.prostaglandins.2011.09.001_bib0480","doi-asserted-by":"crossref","first-page":"H2430","DOI":"10.1152\/ajpheart.2001.280.6.H2430","article-title":"EET homologs potently dilate coronary microvessels and activate BK(Ca) channels","volume":"280","author":"Zhang","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"10.1016\/j.prostaglandins.2011.09.001_bib0485","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1165\/rcmb.2009-0155OC","article-title":"17,18-Epoxyeicosatetraenoic acid targets PPARgamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase","volume":"43","author":"Morin","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0490","doi-asserted-by":"crossref","first-page":"L130","DOI":"10.1152\/ajplung.90436.2008","article-title":"Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung","volume":"296","author":"Morin","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"21","key":"10.1016\/j.prostaglandins.2011.09.001_bib0495","doi-asserted-by":"crossref","first-page":"9886","DOI":"10.1073\/pnas.91.21.9886","article-title":"Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes","volume":"91","author":"Kang","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0500","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1006\/bbrc.1995.1385","article-title":"Prevention and termination of beta-adrenergic agonist-induced arrhythmias by free polyunsaturated fatty acids in neonatal rat cardiac myocytes","volume":"208","author":"Kang","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.prostaglandins.2011.09.001_bib0505","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1073\/pnas.92.9.3997","article-title":"Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes","volume":"92","author":"Kang","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.prostaglandins.2011.09.001_bib0510","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1021\/jm200132q","article-title":"17(R),18(S)-Epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure\u2013activity relationships and stable analogues","volume":"54","author":"Falck","year":"2011","journal-title":"J Med Chem"},{"issue":"Suppl.","key":"10.1016\/j.prostaglandins.2011.09.001_bib0515","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1194\/jlr.R800038-JLR200","article-title":"Arachidonic acid cytochrome P450 epoxygenase pathway","volume":"50","author":"Spector","year":"2009","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.prostaglandins.2011.09.001_bib0520","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1124\/jpet.109.157818","article-title":"20-125Iodo-14,15-epoxyeicosa-5(Z)-enoic acid: a high-affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site","volume":"331","author":"Chen","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"18","key":"10.1016\/j.prostaglandins.2011.09.001_bib0525","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1021\/bi102070w","article-title":"20-Iodo-14,15-epoxyeicosa-8(Z)-enoyl-3-azidophenylsulfonamide: photoaffinity labeling of a 14,15-epoxyeicosatrienoic acid receptor","volume":"50","author":"Chen","year":"2011","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.prostaglandins.2011.09.001_bib0530","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/01.RES.80.6.877","article-title":"Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein","volume":"80","author":"Li","year":"1997","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.prostaglandins.2011.09.001_bib0535","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.bbrc.2005.08.172","article-title":"Human CYP1A1 variants lead to differential eicosapentaenoic acid metabolite patterns","volume":"336","author":"Schwarz","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.prostaglandins.2011.09.001_bib0540","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1194\/jlr.M800199-JLR200","article-title":"Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism","volume":"49","author":"Fer","year":"2008","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.prostaglandins.2011.09.001_bib0545","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/BJ20061328","article-title":"Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation","volume":"403","author":"Muller","year":"2007","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.prostaglandins.2011.09.001_bib0550","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.plefa.2006.05.005","article-title":"Oxygenation of omega-3 fatty acids by human cytochrome P450 4F3B: effect on 20-hydroxyeicosatetraenoic acid production","volume":"75","author":"Harmon","year":"2006","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"2","key":"10.1016\/j.prostaglandins.2011.09.001_bib0555","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.abb.2005.07.003","article-title":"Oxygenation of polyunsaturated long chain fatty acids by recombinant CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of CYP4F8","volume":"441","author":"Stark","year":"2005","journal-title":"Arch Biochem Biophys"},{"issue":"8","key":"10.1016\/j.prostaglandins.2011.09.001_bib0560","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.bcp.2003.12.023","article-title":"Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid","volume":"67","author":"Schwarz","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"37","key":"10.1016\/j.prostaglandins.2011.09.001_bib0565","doi-asserted-by":"crossref","first-page":"22663","DOI":"10.1074\/jbc.271.37.22663","article-title":"The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3","volume":"271","author":"Capdevila","year":"1996","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.prostaglandins.2011.09.001_bib0570","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bcp.2008.10.020","article-title":"Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention","volume":"77","author":"Russo","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"10.1016\/j.prostaglandins.2011.09.001_bib0575","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1074\/jbc.271.7.3460","article-title":"Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart","volume":"271","author":"Wu","year":"1996","journal-title":"J Biol Chem"}],"container-title":["Prostaglandins & Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882311000761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882311000761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T07:45:40Z","timestamp":1638690340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882311000761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":115,"journal-issue":{"issue":"1-4","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1098882311000761"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2011.09.001","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}